Who We Are

PhD researchers, clinical pathologists, and diagnostics industry leaders operating at the intersection of science, technology, and business strategy.

Whether you manage a start-up with a novel marker, a traditional IVD company competing for market share, an established company with a new research platform, a pharmaceutical company struggling with companion diagnostic commercialization, or a clinical laboratory exploring expansion of testing services, the Health Advances Diagnostics and Life Science Tools team can help you realize your business’ potential.

How We Help Your Business

Pragmatic strategies based on deep industry insight.

Featured Areas

Life Science Tools
Lab and Point of Care Product Strategy
Hospital Lab Strategy
Personalized Medicine

Examples

Donna Hochberg: “One of the biggest challenges to commercializing a new research or diagnostic technology is clearly identifying your true target customers. We’ve had a number of recent successes assisting our clients in creatively segmenting customers into easily identifiable and targetable groups, deploying sales reps to the most productive prospects and thereby enabling more effective launch.”

Mark Speers: “It is very fulfilling to be involved with clients periodically as they advance their technologies and see opportunities to refresh their competitive and customer intelligence. Over the course of several years, we assisted a client in the decision to invest in a nascent technology, develop the market to adopt the new technology, and prepare for an exit. The company was recently purchased by a large, established IVD player for several hundred million dollars.”

Gary Gustavsen: “A key focus area for the practice recently has been global commercialization of companion diagnostics. We recently completed a large project for a major biopharma that further validated the need for a globally-orchestrated, but locally-tailored strategy. The barriers to CDx adoption across markets are so unique; every country needs its own set of tactics.”

Case Studies

Diagnostic Assay Global Launch
Drug Discovery Strategy
Test Menu Optimization

View additional diagnostics and life science tools examples here.

Practice Leaders

Contact the Diagnostics and Life Science Tools Team

Related Areas

Oncology
Due Diligence
Reimbursement and Pricing Strategy
Technology Commercialization

Recent News, Events & Publications

07.08.19

Kristine Mechem Joins Health Advances as Vice President

Health Advances is pleased to announce that seasoned life sciences executive, Kristine Mechem, has joined the firm as a Vice President. Kristine will principally focus on Health Advance’s expanding Precision Medicine practice.

With over 15 years of healthcare experience, Kristine has earned an excellent reputation as a skilled strategist and market planning executive. Immediately prior to joining Health Advances, Kristine served as Vice President of Marketing and Planning for OncoCyte Corporation, a publically traded company focused on developing liquid biopsy-based diagnostics for early cancer detection. She was responsible for all aspects of commercial and market planning including product development requirements, market access, commercial operations, and business development initiatives. Kristine was also instrumental in supporting the company through its IPO in early 2016, assisting in various SEC filings and investor relations activities.

Earlier in her career, Kristine was a Director of Business Analytics for Abbott Diabetes Care where she led several market analytics and forecasting initiatives. Prior to that she was a Senior Market Planner at Genentech where she assumed several lifecycle management responsibilities. She has also held Director and VP roles in Business Development for the Zitter Group, Corra Life Sciences, and Invest East of England.

Kristine joins practice leaders Donna Hochberg, Gary Gustavsen, Kate McLaughlin, Kristen Amanti and Peter Origenes in providing strategic advisory services for diagnostics, life science tools and bioproduction clients. Health Advances has been successfully advising companies on the development and commercialization of diagnostic products from traditional core lab platforms, through high value novel diagnostics and precision medicine strategies. Our experienced multi-disciplinary team includes PhD researchers, MDs, and diagnostics industry leaders working to provide innovative strategies for both diagnostic and biopharma clients.


“Health Advances approaches a problem like they’re part of your company and have a real stake in the game. We were a fledgling startup with a novel diagnostic capability and we needed to understand the markets where we could make a big difference in health care. Health Advances looked at the entire landscape of clinical diagnostics and directed us to a market that became a foundation for our company. We’ve now raised over $90 million and grown from 8 to 60 people.”

John McDonough
Chief Executive Officer
T2 Biosystems